ARCHIVES

Nixon Resignation Won’t Hurt Cancer Program, Might Lead To More Money; Weinberger Stays

This article is from The Cancer Letter archive.

Vol. 01 No. 28 | August 16, 1974

Download PDF Visit The Full Archive

Related Articles

Q & A: NCI’s Doroshow Says Phase I Program Will Stress Correlative Studies for Small Biotech Firms

April 6, 2012

Clinical Trials Approved By NCI

October 31, 2003

HHS Hearings to Form National Breast Cancer Strategy. Shalala Says

October 29, 1993

Cech To Step Down At HHMI In 2009.

April 18, 2008

Novel Four Drug Combination Safe For Lung Cancer Therapy

November 28, 2008

Clearinghouse Role Broadened By Upton; Asked To Consider All Data In Risk Assessment

November 11, 1977